BioNTech SE - ADR

NASDAQ:BNTX   4:00:00 PM EDT
97.88
+1.14 (+1.18%)
7:41:11 PM EDT: $97.32 -0.56 (-0.57%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)23.53B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$790.05 Million
Adjusted EPS-$1.22
See more estimates
10-Day MA$101.74
50-Day MA$108.75
200-Day MA$108.29
See more pivots

BioNTech SE - ADR Stock, NASDAQ:BNTX

An der Goldgrube 12, Mainz, Rheinland-Pfalz 55131
Germany
Phone: +49.6131.9084.0
Number of Employees: 6772

Description

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.